Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-25 @ 10:49 PM
Study NCT ID:
NCT03578367
Status:
COMPLETED
Last Update Posted:
2025-11-10
First Post:
2018-06-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-22
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-26
Completion Date Type:
ACTUAL
First Submit Date:
2018-06-15
First Submit QC Date:
None
Study First Post Date:
2018-07-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-10-04
Results First Submit QC Date:
None
Results First Post Date:
2025-02-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-02-14
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-11-05
Last Update Post Date:
2025-11-10
Last Update Post Date Type:
ESTIMATED